JP2021511296A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021511296A5 JP2021511296A5 JP2020537722A JP2020537722A JP2021511296A5 JP 2021511296 A5 JP2021511296 A5 JP 2021511296A5 JP 2020537722 A JP2020537722 A JP 2020537722A JP 2020537722 A JP2020537722 A JP 2020537722A JP 2021511296 A5 JP2021511296 A5 JP 2021511296A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- diabetes
- subject
- limited
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024002422A JP2024028454A (ja) | 2018-01-17 | 2024-01-11 | 糖尿病、肝炎、および／または炎症性肝疾患を治療するための方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862618332P | 2018-01-17 | 2018-01-17 | |
| US62/618,332 | 2018-01-17 | ||
| PCT/US2019/013934 WO2019143767A1 (en) | 2018-01-17 | 2019-01-17 | Methods for treating diabetes, hepatitis, and/or inflammatory liver disease |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024002422A Division JP2024028454A (ja) | 2018-01-17 | 2024-01-11 | 糖尿病、肝炎、および／または炎症性肝疾患を治療するための方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2021511296A JP2021511296A (ja) | 2021-05-06 |
| JP2021511296A5 true JP2021511296A5 (https=) | 2022-01-04 |
| JP7486423B2 JP7486423B2 (ja) | 2024-05-17 |
Family
ID=65324621
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020537722A Active JP7486423B2 (ja) | 2018-01-17 | 2019-01-17 | 糖尿病、肝炎、および／または炎症性肝疾患を治療するための方法 |
| JP2024002422A Pending JP2024028454A (ja) | 2018-01-17 | 2024-01-11 | 糖尿病、肝炎、および／または炎症性肝疾患を治療するための方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024002422A Pending JP2024028454A (ja) | 2018-01-17 | 2024-01-11 | 糖尿病、肝炎、および／または炎症性肝疾患を治療するための方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (3) | US11866488B2 (https=) |
| EP (2) | EP4596042A3 (https=) |
| JP (2) | JP7486423B2 (https=) |
| KR (2) | KR102937161B1 (https=) |
| CN (2) | CN120267797A (https=) |
| AU (2) | AU2019209491B2 (https=) |
| BR (1) | BR112020014346A2 (https=) |
| CA (1) | CA3088661A1 (https=) |
| EA (1) | EA202091533A1 (https=) |
| ES (1) | ES3033317T3 (https=) |
| HR (1) | HRP20250727T1 (https=) |
| HU (1) | HUE072418T2 (https=) |
| IL (2) | IL316486A (https=) |
| MX (1) | MX2020007384A (https=) |
| PH (1) | PH12020551076A1 (https=) |
| PL (1) | PL3740282T3 (https=) |
| RS (1) | RS66918B1 (https=) |
| SG (1) | SG11202006421RA (https=) |
| SM (1) | SMT202500233T1 (https=) |
| WO (1) | WO2019143767A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2020234718A1 (en) | 2019-03-13 | 2023-05-18 | Tearsolutions, Inc. | Compositions and methods for promoting islet viability and enhancing insulin secretion |
| EP3999531A1 (en) * | 2019-07-15 | 2022-05-25 | University of Connecticut | Metallothionein antibodies and their use |
| CN110551726B (zh) * | 2019-09-06 | 2021-04-09 | 上海市肺科医院 | 一种结核杆菌阿拉伯半乳聚糖适配子及其应用 |
| US11478533B2 (en) | 2020-04-27 | 2022-10-25 | Novo Nordisk A/S | Semaglutide for use in medicine |
| KR102191405B1 (ko) * | 2020-09-15 | 2020-12-16 | 주식회사 에이스바이오메드 | 간 질환 예방 또는 치료용 조성물 |
| CN115317502B (zh) * | 2021-12-21 | 2023-07-07 | 青岛市市立医院 | 一种线性硬毛藻提取的粗多糖在制备非酒精性脂肪性肝药物中的应用 |
| WO2025226837A1 (en) * | 2024-04-24 | 2025-10-30 | University Of Connecticut | Anti-bacterial metallothionein antibodies and uses thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9809951D0 (en) | 1998-05-08 | 1998-07-08 | Univ Cambridge Tech | Binding molecules |
| US20030007973A1 (en) | 2001-06-22 | 2003-01-09 | Lynes Michael A. | Methods and compositions for manipulation of the immune response using anti-metallothionein antibody |
| CA2658673A1 (en) | 2005-07-27 | 2008-02-01 | Gerald J. Prud'homme | Composition and method for prevention and treatment of type i and type ii diabetes |
| WO2011050052A2 (en) * | 2009-10-20 | 2011-04-28 | Georgia State University Research Foundation, Inc. | Protein agent for diabetes treatment and beta cell imaging |
| CA2813711A1 (en) | 2010-10-14 | 2012-04-19 | Immunahr Ab | 1,2-dihydro-4-hydroxy-2-oxo-quinoline-3-carboxanilides as ahr activators. |
| CA2840282C (en) | 2011-07-08 | 2018-11-13 | Universiteit Gent | Use of antagonists targeting metallothionein to treat intestinal inflammation |
| WO2014172606A1 (en) * | 2013-04-19 | 2014-10-23 | The Brigham And Women's Hospital, Inc. | Methods for modulating immune responses during chronic immune conditions by targeting metallothioneins |
| TR201402685A1 (tr) | 2014-03-06 | 2015-09-21 | Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi | Vildagliptinin farmasotik formulasyonları. |
| EP3149049B1 (en) * | 2014-05-27 | 2022-10-26 | The University Of Queensland | Il-22 for use in treating metabolic disorders |
| TW201613949A (en) | 2014-08-07 | 2016-04-16 | Regulus Therapeutics Inc | Targeting microRNAs for metabolic disorders |
-
2019
- 2019-01-17 MX MX2020007384A patent/MX2020007384A/es unknown
- 2019-01-17 SG SG11202006421RA patent/SG11202006421RA/en unknown
- 2019-01-17 CA CA3088661A patent/CA3088661A1/en active Pending
- 2019-01-17 RS RS20250601A patent/RS66918B1/sr unknown
- 2019-01-17 KR KR1020207022117A patent/KR102937161B1/ko active Active
- 2019-01-17 JP JP2020537722A patent/JP7486423B2/ja active Active
- 2019-01-17 ES ES19703874T patent/ES3033317T3/es active Active
- 2019-01-17 WO PCT/US2019/013934 patent/WO2019143767A1/en not_active Ceased
- 2019-01-17 HU HUE19703874A patent/HUE072418T2/hu unknown
- 2019-01-17 IL IL316486A patent/IL316486A/en unknown
- 2019-01-17 EA EA202091533A patent/EA202091533A1/ru unknown
- 2019-01-17 SM SM20250233T patent/SMT202500233T1/it unknown
- 2019-01-17 CN CN202510512846.1A patent/CN120267797A/zh active Pending
- 2019-01-17 PL PL19703874.8T patent/PL3740282T3/pl unknown
- 2019-01-17 IL IL276097A patent/IL276097B2/en unknown
- 2019-01-17 US US16/961,327 patent/US11866488B2/en active Active
- 2019-01-17 AU AU2019209491A patent/AU2019209491B2/en active Active
- 2019-01-17 EP EP25158063.5A patent/EP4596042A3/en active Pending
- 2019-01-17 EP EP19703874.8A patent/EP3740282B1/en active Active
- 2019-01-17 KR KR1020267006914A patent/KR20260042289A/ko active Pending
- 2019-01-17 CN CN201980008316.6A patent/CN111801140B/zh active Active
- 2019-01-17 HR HRP20250727TT patent/HRP20250727T1/hr unknown
- 2019-01-17 BR BR112020014346-4A patent/BR112020014346A2/pt unknown
-
2020
- 2020-07-14 PH PH12020551076A patent/PH12020551076A1/en unknown
-
2022
- 2022-08-12 AU AU2022215285A patent/AU2022215285B2/en active Active
-
2023
- 2023-07-24 US US18/357,632 patent/US12583916B2/en active Active
- 2023-10-27 US US18/496,279 patent/US20240067710A1/en active Pending
-
2024
- 2024-01-11 JP JP2024002422A patent/JP2024028454A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021511296A5 (https=) | ||
| Zheng et al. | Glucagon-like peptide-1 receptor: mechanisms and advances in therapy | |
| US12583916B2 (en) | Methods to improve glucose tolerance in a subject by administering an antibody that binds to extracellular human metallothionein 1A (MT1A) | |
| JP7761557B2 (ja) | グルカゴン、及びｇｌｐ－１受容体及びｇｉｐ受容体二重アゴニストを含む組成物及びその治療学的使用 | |
| JP2025169470A (ja) | Ｇｌｐ－１ｒアゴニスト／ｆｇｆ２１融合タンパク質 | |
| Soudahome et al. | Glycation of human serum albumin impairs binding to the glucagon-like peptide-1 analogue liraglutide | |
| RU2719144C2 (ru) | Композиция, включающая агонист рецептора glp-1 и агонист глюкагонового рецептора, и ее применение | |
| JP2025169473A (ja) | 低減された活性を有するｇｌｐ－１ｒアゴニストペプチド | |
| US12551541B2 (en) | Albumin bound macromolecule tri-agonist activating GLP 1/GIP/glucagon receptors and methods therefor | |
| RU2857186C2 (ru) | Рекомбинантный пептид на основе GLP-1, модифицированный по С-концу последовательностью CRAC и обладающий антигипергликемическими свойствами активной формы глюкагоноподобного пептида 1 типа GLP-1 (7-37), и плазмида, обеспечивающая экспрессию рекомбинантного пептида GLP-1 в клетках Е. coli | |
| Alharbi | A mini review on glucagon-like peptide-1 receptor agonists and its role in blood pressure regulation | |
| EA048509B1 (ru) | Способы лечения диабета, гепатита и/или воспалительного заболевания печени | |
| Baretić et al. | Association of blood pressure and body weight decline during one-year treatment with the incretin analogue exenatide. | |
| HK40040177A (en) | Metallothionein inhibitors for treating diabetes, hepatitis, and/or inflammatory liver disease | |
| HK40040177B (en) | Metallothionein inhibitors for treating diabetes, hepatitis, and/or inflammatory liver disease | |
| WO2018113340A1 (zh) | 多肽p11及其用途 |